Drug intelligence / Profile preview

deoxycorticosterone acetate

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Intramuscular
01

Overview

**Deoxycorticosterone acetate** is a synthetic **mineralocorticoid** steroid hormone ester, chemically identified as the C21 acetate ester of 11-deoxycorticosterone. It acts as a prodrug, releasing active deoxycorticosterone after intramuscular injection. Deoxycorticosterone acetate functions as a potent mineralocorticoid, primarily *increasing renal tubular sodium reabsorption* and promoting potassium excretion, mimicking the biological effects of aldosterone. Its mechanism involves binding mineralocorticoid receptors in the cytoplasm of renal tubular cells, leading to gene transcription and upregulation of protein synthesis responsible for electrolyte homeostasis. It has historically been used in adrenal insufficiency (Addison’s disease), especially before the availability of fludrocortisone, but is primarily used now as an animal pharmaceutical for replacement therapy in veterinary medicine[1][2][3][5]. In research, it is widely used to induce hypertension in laboratory animal models[4][8].

Brand names
Percorten AcetateDecosteronePercotolCortacetCortenilSyncortylSincortex
Other names
desoxycorticosterone acetatedesoxycortone acetatedeoxycorticosterone-21-acetatedeoxycorticosterone21-acetatedeoxycorticosterone 21-acetatecortexone acetatedesoxycorticosterone 21-acetatedesoxycorticosterone21-acetatedesoxycorticosterone-21-acetatedoc 21 acetatedoc21 acetatedoc-21 acetatedoc-acetate
02

Targets

MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on deoxycorticosterone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deoxycorticosterone acetate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call